Cargando…
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma
Multiple myeloma (MM) is the second most common hematological malignancy, arising from terminally differentiated B cells, namely plasma cells. miRNAs are small non-coding RNAs that participate in the post-transcriptional regulation of gene expression. In this study, we investigated the role of nine...
Autores principales: | Papanota, Aristea-Maria, Karousi, Paraskevi, Kontos, Christos K., Artemaki, Pinelopi I., Liacos, Christine-Ivy, Papadimitriou, Maria-Alexandra, Bagratuni, Tina, Eleutherakis-Papaiakovou, Evangelos, Malandrakis, Panagiotis, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Kastritis, Efstathios, Avgeris, Margaritis, Dimopoulos, Meletios-Athanasios, Scorilas, Andreas, Terpos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658678/ https://www.ncbi.nlm.nih.gov/pubmed/34884950 http://dx.doi.org/10.3390/ijms222313144 |
Ejemplares similares
-
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021) -
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature
por: Karousi, Paraskevi, et al.
Publicado: (2021) -
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2023) -
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
por: Papanota, Aristea-Maria, et al.
Publicado: (2021) -
Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma
por: Terpos, Evangelos, et al.
Publicado: (2018)